Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Filings indexed 392 across all filing types
Latest filing 2024-01-25 Regulatory Filings
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the loss of share certificates by a shareholder. It references Regulation 39(3) of the SEBI Listing Regulations, which pertains to reporting lost or stolen share certificates. The content is an announcement of a specific event related to shareholding records, not a financial report, audit, management discussion, or any other detailed report type. It does not contain financial data, earnings information, or meeting materials. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other specific categories.
2024-01-25 English
Board Meeting — CHEMFAB ALKALIS LIMITED has informed the Exchange about Board Meeting to be held on 08-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for t…
Regulatory Filings
2024-01-25 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about an upcoming Board Meeting scheduled to approve the quarterly financial results for the period ended December 31, 2023. It references compliance with SEBI regulations regarding disclosure and insider trading. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of a future event (Board Meeting) related to financial reporting, not the report itself. The document length is short (1628 characters), and it serves as a notification rather than a report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-01-25 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a submission letter addressed to stock exchanges regarding the Reconciliation of Share Capital Audit Report for the quarter ended 31st December 2023. It references Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018, and states that the audit report is being submitted as required. The document itself is a cover letter or announcement of the audit report, not the audit report or reconciliation report itself. The length is short (1264 characters), and it primarily serves to notify the regulatory bodies of the submission. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is an official regulatory announcement and does not contain the full audit report or detailed financial data.
2024-01-16 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate submitted under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms the dematerialization of share certificates for the quarter ended 31st December 2023. The document is addressed to stock exchanges and signed by the company secretary and the registrar and share transfer agent. It is a regulatory compliance certificate rather than a financial report or announcement of financial results. The document length is short (2909 characters) and it does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and regulatory announcements that do not fit other specific categories.
2024-01-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI regulations ahead of the announcement of the company's quarterly financial results. It mentions the upcoming announcement of the Un-Audited Standalone and Consolidated Financial Results for the quarter ended 31st December 2023 but does not contain any financial data or the results themselves. The document is short (1586 characters) and serves as a notification about trading restrictions prior to the earnings release. Therefore, it is neither the earnings release nor the financial report but a regulatory announcement related to insider trading compliance. This fits best under Regulatory Filings (RNS).
2023-12-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.